The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

AIM WINNERS & LOSERS: Touchstone up on gas find, C4X on Sanofi deal

Mon, 12th Apr 2021 11:28

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Touchstone Exploration Inc, up 17% at 107.00 pence, 12-month range 22.2p-178p. The oil and gas explorer says flowback testing of one of its wells in Trinidad & Tobago confirmed a liquids-rich natural gas discovery. President & Chief Executive Paul Baay notes that the test results "demonstrate the clear future production opportunities for the company."

----------

C4X Discovery PLC, up 12% at 44.85p, 12-month range 11.5p-54.5p. The drug development firm signs exclusive worldwide licensing agreement with Sanofi SA for C4XD's oral pre-clinical IL-17A inhibitor programme. C4XD will receive an upfront payment of EUR7 million and could receive up to a further EUR407 million in potential development, regulatory and commercialisation milestones, of which EUR11 million is in pre-clinical milestones, in addition to single-digit royalties. Sanofi shares were up 0.2% in Paris.

----------

Elixirr International PLC, up 11% at 479p, 12-month range 185p-480p. The London-based consultancy says it performed "exceptionally well" in 2020. Elixirr International says 2020 revenue rose by 24% to GBP30.3 million from GBP24.5 million and pretax profit was up to GBP5.8 million from GBP1.7 million. Says trading in first quarter has been strong with revenue increasing by more than 60%.

----------

AIM - LOSERS

----------

Concurrent Technologies PLC, down 8.9% at 95.70p, 12-month range 82p-126p. The embedded computer products manufacturer says some project delays could see revenue shifting to 2022. Pretax profit in 2020 fell 32% to GBP2.8 million from GBP4.1 million in 2019. Revenue, however, improved 8.8% to GBP21.1 million from GBP19.4 million. Looking ahead, Concurrent says it is taking a cautious approach to revenue growth in the coming year because of the continuing uncertainty caused by the Covid-19 outbreak and the delays seen to some programmes potentially moving revenue from 2021 to 2022.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
25 Apr 2024 20:57

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

15 Apr 2024 14:17

IN BRIEF: C4X Discovery shareholders approve of taking firm private

C4X Discovery Holdings PLC - Manchester, England-based drug discovery company - Shareholders pass all resolutions at general meeting, including resolu...

8 Apr 2024 14:26

UK shareholder meetings calendar - next 7 days

27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downt...

16 Jan 2024 15:27

UK shareholder meetings calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.